NCT00234052 Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00227617 Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors Status TERMINATED Phase PHASE2/PHASE3
NCT00227019 Phase 2 Trial of Bevacizumab in Combination With Pemetrexed Status COMPLETED Phase PHASE2
NCT00222729 Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00222469 Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00217737 Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00217672 Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00217581 Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00217503 Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma Status COMPLETED Phase PHASE2
NCT00217425 Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms Status COMPLETED Phase PHASE2
NCT00203502 Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00203411 Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00193622 Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site Status COMPLETED Phase PHASE2
NCT00193492 A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00193375 Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00193258 Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00193219 Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00193154 OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00177307 Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00165568 Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2